Beata Juzyna

Beata Juzyna currently serves as the Head of the Gastrointestinal & Gynecology Group at Unicancer, where she leverages her extensive expertise in clinical development to advance innovative oncology research. In this strategic leadership role, Beata oversees a diverse portfolio of key projects focused on improving patient outcomes through the development of targeted therapies and personalized treatment approaches within gastrointestinal and gynecological cancers. Her deep understanding of all phases of clinical trials—from design and planning to execution and regulatory submission—enables her to effectively coordinate multidisciplinary teams across international sites, ensuring compliance with ICH-GCP standards and SOPs.

At Unicancer, Beata plays a pivotal role in fostering collaboration between academic research and industry partners, promoting themes of public health relevance and patient access to cutting-edge oncology innovations. Her proactive and flexible management style, combined with well-developed interpersonal skills, facilitates seamless communication among stakeholders, including CROs, regulatory authorities, and clinical investigators. She is particularly adept at navigating complex regulatory landscapes, ensuring smooth regulatory submissions and adherence to industry best practices in pharmaceutical and biotechnology research.

Her expertise extends to implementing robust clinical operations strategies, optimizing trial workflows, and managing cross-functional teams to meet project milestones efficiently. Beata’s leadership not only accelerates the translation of scientific discoveries into clinical applications but also reinforces Unicancer’s reputation as a major academic operator in oncology research. Her commitment to advancing therapeutic options in gastrointestinal and gynecological cancers underscores her dedication to improving patient access to innovative treatments and contributing to the broader scientific community’s efforts in combating cancer.